SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-24-000500
Filing Date
2024-05-20
Accepted
2024-05-20 17:01:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE 13G achieve13ga2-123123.htm SC 13G/A 146070
  Complete submission text file 0001013594-24-000500.txt   147846
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45969 | Film No.: 24965520
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 22 FIELDVIEW LANE EAST HAMPTON NY 11937
Business Address 22 FIELDVIEW LANE EAST HAMPTON NY 11937 917-923-7400
Contrarian Alpha, LP (Filed by) CIK: 0001921222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A